Sage Therapeutics (SAGE)
(Delayed Data from NSDQ)
$6.64 USD
-0.35 (-5.01%)
Updated Oct 4, 2024 04:00 PM ET
After-Market: $6.64 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value B Growth B Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/05/2024
Time: -- |
9/2024 | $-1.54 | 0.00% |
Earnings Summary
For their last quarter, Sage Therapeutics (SAGE) reported earnings of -$1.70 per share, missing the Zacks Consensus Estimate of -$1.68 per share. This reflects a negative earnings surprise of 1.19%. Look out for SAGE's next earnings release expected on November 05, 2024. For the next earning release, we expect the company to report earnings of -$1.54 per share, reflecting a year-over-year increase of 45.2%.
Earnings History
Price & Consensus
Zacks News for SAGE
Biogen Stock Declines 20.9% Year to Date: Time to Sell?
SAGE: What are Zacks experts saying now?
Zacks Private Portfolio Services